Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.

Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe webpage has been updated to include new drugs for the treatment of Multiple Myeloma, such as Lenalidomide, Bortezomib, Pomalidomide, Isatuximab, Fianlimab, Cemiplimab, and Nirogacestat, while removing detailed information about a previous study involving linvoseltamab.SummaryDifference37%
- Check19 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 7, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check27 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 7, 2025.SummaryDifference0.1%
- Check49 days agoChange DetectedThe webpage has updated its location listings, adding new entries for hospitals in Paris and Lille while removing previous listings for the same locations. Additionally, the dates have been updated to reflect more recent information.SummaryDifference2%
- Check63 days agoChange DetectedThe page has updated key location and institutional names, including a change from 'University of Texas Southwestern Medical Center' to 'University of Texas Southwestern' and from 'CHU de Montpellier' to 'CHU Montpellier - Departement D'Hematologie'. Additionally, there are new dates listed.SummaryDifference1%
- Check70 days agoChange DetectedThe page has updated its location details for Angers, France, and Pamplona, Spain, including a change in postal codes and the name of the hospital. Additionally, the recruitment status has been changed to 'Not yet recruiting'.SummaryDifference1.0%
Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.